These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8123262)

  • 1. WAIS-R subtest profile and cortical perfusion in Alzheimer's disease.
    Alexander GE; Prohovnik I; Stern Y; Mayeux R
    Brain Cogn; 1994 Jan; 24(1):24-43. PubMed ID: 8123262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuld's formula and WAIS subtests in differential diagnosis of dementia.
    Caffarra P; Scaglioni A; Malvezzi L; Girotti F; Soliveri P; Musicco M; Previdi P
    Funct Neurol; 1991; 6(1):23-7. PubMed ID: 2055547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wechsler Intelligence Scale profiles, the cholinergic system, and Alzheimer's disease.
    Filley CM; Kobayashi J; Heaton RK
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):180-6. PubMed ID: 3558750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Education and cognitive function in Alzheimer's disease.
    Filley CM; Cullum CM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jan; 10(1):48-51. PubMed ID: 9118196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.
    Satz P; Van Gorp WG; Soper HV; Mitrushina M
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):767-74. PubMed ID: 3693533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
    Satz P; Hynd GW; D'Elia L; Daniel MH; Van Gorp W; Connor R
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):759-65. PubMed ID: 2258435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease.
    Oda H; Yamamoto Y; Maeda K
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):125-31. PubMed ID: 18615776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
    Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal sensitivity of the Fuld cholinergic profile to Alzheimer's disease.
    Goldman RS; Axelrod BN; Giordani BJ; Foster N; Berent S
    J Clin Exp Neuropsychol; 1992 Jul; 14(4):566-74. PubMed ID: 1400919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease.
    Keilp JG; Alexander GE; Stern Y; Prohovnik I
    Brain Cogn; 1996 Dec; 32(3):365-83. PubMed ID: 8975677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the diagnostic utility of the Fuld cholinergic deficit profile on the Japanese WAIS-R.
    Yamashita H; Hirono N; Ikeda M; Ikejiri Y; Imamura T; Shimomura T; Mori E
    J Clin Exp Neuropsychol; 1997 Apr; 19(2):300-4. PubMed ID: 9240488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The WAIS-R profile: a diagnostic tool for Alzheimer's disease?
    Logsdon RG; Teri L; Williams DE; Vitiello MV; Prinz PN
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):892-8. PubMed ID: 2592529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M; Namiki C; Thuy DH; Yoshida H; Kawasaki K; Hashikawa K; Fukuyama H; Kita T
    J Neurol Sci; 2004 Oct; 225(1-2):135-41. PubMed ID: 15465097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of age-decline resistant ("hold") WAIS subtests to Alzheimer's disease.
    Larrabee GJ; Largen JW; Levin HS
    J Clin Exp Neuropsychol; 1985 Oct; 7(5):497-504. PubMed ID: 4066906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease.
    Stern Y; Alexander GE; Prohovnik I; Mayeux R
    Ann Neurol; 1992 Sep; 32(3):371-5. PubMed ID: 1416806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.